Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Shares Outstanding (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Shares Outstanding for 10 consecutive years, with $43236.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Shares Outstanding changed N/A year-over-year to $43236.0, compared with a TTM value of $43236.0 through Dec 2023, changed N/A, and an annual FY2023 reading of $43236.0, changed N/A over the prior year.
  • Shares Outstanding was $43236.0 for Q4 2023 at Lisata Therapeutics, roughly flat from $43236.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $43236.0 in Q3 2023 and bottomed at $43236.0 in Q3 2023.